Protagonist Therapeutics (PTGX) market cap

Market cap today
$8.14B

Protagonist Therapeutics (PTGX) has a market cap of $8.14B. At the end of fiscal 2025 (December 31, 2025) its market cap was $5.55B. That is 121.0% higher than the $2.51B of fiscal 2024. Today's figure is 46.6% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$8.14B
Market cap, fiscal 2025
$5.55B
Change on fiscal 2024
+121.0%
Growth, 5 years
+51.6% a year
Highest on record
$5.55Bfiscal 2025
Lowest on record
$535.05Mfiscal 2022
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Protagonist Therapeutics market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 51.6% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $5.55B in fiscal 2025 and the lowest $535.05M in fiscal 2022.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Protagonist Therapeutics market cap, year by year

Protagonist Therapeutics (PTGX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$8.14B—$124.67—
2025$5.55B 121.0% up$87.3463.57M
2024$2.51B 93.0% up$38.6065.08M
2023$1.30B 143.3% up$22.9356.76M
2022$535.05M 66.2% down$10.9149.04M
2021$1.58B 128.5% up$34.2046.32M
2020$693.43M—$20.1634.40M
2019——$7.05—
2018——$6.73—
2017——$20.80—
2016——$21.99—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on PTGX

Protagonist Therapeutics, figure by figure

Protagonist Therapeutics (PTGX) overview: price, valuation and scorecardAll health care companies by market value

Protagonist Therapeutics market cap: questions and answers

What is Protagonist Therapeutics's market cap?

Protagonist Therapeutics (PTGX) has a market cap of $8.14B. At the end of fiscal 2025 (December 31, 2025) its market cap was $5.55B. That is 121.0% higher than the $2.51B of fiscal 2024.

What is the growth rate of Protagonist Therapeutics's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 51.6% a year.

What are the highest and lowest market cap figures on record for Protagonist Therapeutics?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $5.55B in fiscal 2025 and the lowest $535.05M in fiscal 2022.

How is Protagonist Therapeutics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Protagonist Therapeutics it is on record here for 6 fiscal years, 2020 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Protagonist Therapeutics (PTGX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/PTGX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.